| Title | Research Area | Implementing Organisations | Funding Organisations | Start Year | Status |
|---|---|---|---|---|---|
| Chalo Milo CCMB | Other Areas | Centre for Cellular and Molecular Biology (CCMB) | Department of Science and Technology (DST) | 2020 | Completed |
| Molecular basis of evolutionary divergence in RNAi initiation | Life Sciences & Biotechnology | Centre for Cellular and Molecular Biology (CCMB) | Council of Scientific & Industrial Research (CSIR) | 2020 | Completed |
| Organoid models for biomedical research applications | Life Sciences & Biotechnology | Centre for Cellular and Molecular Biology (CCMB) | Council of Scientific & Industrial Research (CSIR) | 2020 | Completed |
| Development of an inactivated SARS-CoV2 vaccine for COVID-19 (ICoV2Vac) | Medical Sciences | Centre for Cellular and Molecular Biology (CCMB) | Council of Scientific & Industrial Research (CSIR) | 2020 | Completed |
| Investigating interactions at the host-pathogen interface in the pathogenesis of Mycobacterium tuberculosis | Life Sciences & Biotechnology | Centre for Cellular and Molecular Biology (CCMB) | Council of Scientific & Industrial Research (CSIR) | 2020 | Completed |
| Biology of aging and age related disorders | Life Sciences & Biotechnology | Centre for Cellular and Molecular Biology (CCMB) | Council of Scientific & Industrial Research (CSIR) | 2020 | Completed |
| Homocysteine Specific Novel Sensor for Diagnostic Use | Chemical Sciences | Centre for Cellular and Molecular Biology (CCMB) | Council of Scientific & Industrial Research (CSIR) | 2020 | Completed |
| Understanding molecular mechanism in depression and fast acting antidepressants | Medical Sciences | Centre for Cellular and Molecular Biology (CCMB) | Council of Scientific & Industrial Research (CSIR) | 2020 | Completed |
| Mechanistic insights into bacterial growth and morphogenesis | Life Sciences & Biotechnology | Centre for Cellular and Molecular Biology (CCMB) | Council of Scientific & Industrial Research (CSIR) | 2020 | Completed |
| Development of META1 as a druggable target against Leishmaniasis | Pharmaceutical Sciences | Centre for Cellular and Molecular Biology (CCMB) | Council of Scientific & Industrial Research (CSIR) | 2020 | Completed |
Accessibility Controls